You are here

US - NorthWest

Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine

On June 26, a small South San Francisco company called Vaxart made a surprise announcement: A coronavirus vaccine it was working on had been selected by the U.S. government to be part of Operation Warp Speed, the flagship federal initiative to quickly develop drugs to combat Covid-19.

Vaxart’s shares soared. Company insiders, who weeks earlier had received stock options worth a few million dollars, saw the value of those awards increase sixfold. And a hedge fund that partly controlled the company walked away with more than $200 million in instant profits.

Problem, Solution, SitRep, or ?: 

Coronavirus Testing Labs Again Lack Key Supplies

Labs across the country are facing backlogs in coronavirus testing thanks in part to a shortage of tiny pieces of tapered plastic.

Researchers need these little disposables, called pipette tips, to quickly and precisely move liquid between vials as they process the tests.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to US - NorthWest
howdy folks
Page loaded in 0.674 seconds.